Lotiglipron

1 1

Selleck Chemicals

E1602-5MG

€193,00 EUR
€193,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

Lotiglipron is an agonist linked to GPCR Signaling and related pathway-oriented research. It is especially relevant in endocrinology models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

The pathway annotation connects Lotiglipron to GPCR Signaling, supporting experiments that monitor receptor-driven second-messenger signaling and desensitization dynamics across biochemical, cellular, or phenotypic assay formats. This context is compatible with ligand-response, cAMP, calcium-flux, and receptor-pharmacology assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to GPCR Signaling
  • Agonist-response and downstream signaling studies
  • Phenotypic profiling in endocrinology models
  • Combination studies with orthogonal perturbagens

Overall, Lotiglipron is well suited to pathway-oriented studies that need a defined compound input for GPCR Signaling readouts in endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
GPCR Signaling
Research Area:
Endocrinology
CAS No.:
2401892-75-7
Molecular Weight:
575.06
Formula:
C₃₁H₃₁ClN₄O₅
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.